227 related articles for article (PubMed ID: 12879463)
41. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.
Mikami S; Ohashi K; Usui Y; Nemoto T; Katsube K; Yanagishita M; Nakajima M; Nakamura K; Koike M
Jpn J Cancer Res; 2001 Oct; 92(10):1062-73. PubMed ID: 11676857
[TBL] [Abstract][Full Text] [Related]
42. Measurement of neovascularization is an independent prognosticator of survival in node-negative breast cancer patients with long-term follow-up.
De Placido S; Carlomagno C; Ciardiello F; De Laurentiis M; Pepe S; Ruggiero A; Tortora G; Panico L; D'Antonio A; Pettinato G; Petrella G; Bianco AR
Clin Cancer Res; 1999 Oct; 5(10):2854-9. PubMed ID: 10537353
[TBL] [Abstract][Full Text] [Related]
43. Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours.
Curmi PA; Noguès C; Lachkar S; Carelle N; Gonthier MP; Sobel A; Lidereau R; Bièche I
Br J Cancer; 2000 Jan; 82(1):142-50. PubMed ID: 10638981
[TBL] [Abstract][Full Text] [Related]
44. c-erbB-4 protein expression in human breast cancer.
Kew TY; Bell JA; Pinder SE; Denley H; Srinivasan R; Gullick WJ; Nicholson RI; Blamey RW; Ellis IO
Br J Cancer; 2000 Mar; 82(6):1163-70. PubMed ID: 10735500
[TBL] [Abstract][Full Text] [Related]
45. Elevated levels of syndecan-1 expression confer potent serum-dependent growth in human 293T cells.
Numa F; Hirabayashi K; Tsunaga N; Kato H; O'Rourke K; Shao H; Stechmann-Lebakken C; Varani J; Rapraeger A; Dixit VM
Cancer Res; 1995 Oct; 55(20):4676-80. PubMed ID: 7553648
[TBL] [Abstract][Full Text] [Related]
46. Steroid sulfatase expression is an independent predictor of recurrence in human breast cancer.
Utsumi T; Yoshimura N; Takeuchi S; Ando J; Maruta M; Maeda K; Harada N
Cancer Res; 1999 Jan; 59(2):377-81. PubMed ID: 9927050
[TBL] [Abstract][Full Text] [Related]
47. Expression of syndecan-1 and -3 during embryogenesis of the central nervous system in relation to binding with midkine.
Nakanishi T; Kadomatsu K; Okamoto T; Ichihara-Tanaka K; Kojima T; Saito H; Tomoda Y; Muramatsu T
J Biochem; 1997 Feb; 121(2):197-205. PubMed ID: 9089390
[TBL] [Abstract][Full Text] [Related]
48. Hormonal therapy with megestrol in inoperable hepatocellular carcinoma characterized by variant oestrogen receptors.
Villa E; Ferretti I; Grottola A; Buttafoco P; Buono MG; Giannini F; Manno M; Bertani H; Dugani A; Manenti F
Br J Cancer; 2001 Apr; 84(7):881-5. PubMed ID: 11286465
[TBL] [Abstract][Full Text] [Related]
49. C-erbB-2 oncoprotein content in colorectal cancer and in surrounding mucosa: relationship with clinicopathologic parameters and prognostic significance.
Vizoso F; Villar C; Rodríguez JC; Raigoso P; García-Muñiz JL; Allende MT; García-Moran M
Int J Surg Investig; 2000; 1(6):483-93. PubMed ID: 11729856
[TBL] [Abstract][Full Text] [Related]
50. Differentiation of mesothelioma cells is influenced by the expression of proteoglycans.
Dobra K; Andäng M; Syrokou A; Karamanos NK; Hjerpe A
Exp Cell Res; 2000 Jul; 258(1):12-22. PubMed ID: 10912783
[TBL] [Abstract][Full Text] [Related]
51. Syndecan-1 expression in cancer of the uterine cervix: association with lymph node metastasis.
Numa F; Hirabayashi K; Kawasaki K; Sakaguchi Y; Sugino N; Suehiro Y; Suminami Y; Hirakawa H; Umayahara K; Nawata S; Ogata H; Kato H
Int J Oncol; 2002 Jan; 20(1):39-43. PubMed ID: 11743640
[TBL] [Abstract][Full Text] [Related]
52. Proline-rich antimicrobial peptide, PR-39 gene transduction altered invasive activity and actin structure in human hepatocellular carcinoma cells.
Ohtake T; Fujimoto Y; Ikuta K; Saito H; Ohhira M; Ono M; Kohgo Y
Br J Cancer; 1999 Oct; 81(3):393-403. PubMed ID: 10507762
[TBL] [Abstract][Full Text] [Related]
53. Prognostic value of the type I growth factor receptors in a large series of human primary breast cancers quantified with a real-time reverse transcription-polymerase chain reaction assay.
Pawlowski V; Révillion F; Hebbar M; Hornez L; Peyrat JP
Clin Cancer Res; 2000 Nov; 6(11):4217-25. PubMed ID: 11106235
[TBL] [Abstract][Full Text] [Related]
54. Differential regulation of syndecan expression by osteosarcoma cell lines in response to cytokines but not osteotropic hormones.
Birch MA; Skerry TM
Bone; 1999 Jun; 24(6):571-8. PubMed ID: 10375199
[TBL] [Abstract][Full Text] [Related]
55. Prognostic relevance of three histological grading methods in breast cancer.
Latinovic L; Heinze G; Birner P; Samonigg H; Hausmaninger H; Kubista E; Kwasny W; Gnant M; Jakesz R; Oberhuber G;
Int J Oncol; 2001 Dec; 19(6):1271-7. PubMed ID: 11713599
[TBL] [Abstract][Full Text] [Related]
56. Time-dependent increases in syndecan-1 and fibroglycan messenger RNA expression in the infarct zone after experimentally induced myocardial infarction in rats.
Endo C; Kusachi S; Ninomiya Y; Yamamoto K; Murakami M; Murakami T; Shinji T; Koide N; Kondo J; Tsuji T
Coron Artery Dis; 1997; 8(3-4):155-61. PubMed ID: 9237025
[TBL] [Abstract][Full Text] [Related]
57. Syndecan-1 expression is decreased with increasing aggressiveness of basal cell carcinoma.
Bayer-Garner IB; Dilday B; Sanderson RD; Smoller BR
Am J Dermatopathol; 2000 Apr; 22(2):119-22. PubMed ID: 10770430
[TBL] [Abstract][Full Text] [Related]
58. Prognostic and predictive significance of ErbB-2 breast tumor levels measured by enzyme immunoassay.
Eppenberger-Castori S; Kueng W; Benz C; Caduff R; Varga Z; Bannwart F; Fink D; Dieterich H; Hohl M; Müller H; Paris K; Schoumacher F; Eppenberger U
J Clin Oncol; 2001 Feb; 19(3):645-56. PubMed ID: 11157014
[TBL] [Abstract][Full Text] [Related]
59. Local expression of complement factor I in breast cancer cells correlates with poor survival and recurrence.
Okroj M; Holmquist E; Nilsson E; Anagnostaki L; Jirström K; Blom AM
Cancer Immunol Immunother; 2015 Apr; 64(4):467-78. PubMed ID: 25618258
[TBL] [Abstract][Full Text] [Related]
60. Cell surface proteoglycan expression by human periodontal cells.
Worapamorn W; Li H; Haas HR; Pujic Z; Girjes AA; Bartold PM
Connect Tissue Res; 2000; 41(1):57-68. PubMed ID: 10826709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
